Search Within

Martin Henner Voss

  1. "MSK Grad Students"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (4)
Groups
  1. Department of Medicine (12)
  2. Genitourinary Oncology Service (12)
  3. Human Oncology and Pathogenesis Program (12)
  4. MSK Grad Students (12)
  5. Solid Tumor Oncology Division (12)
  6. Surgery (12)

More Groups

People
  1. Abraham Hakimi (12)
  2. Robert Motzer (10)
  3. Paul Russo (8)
  4. Eduard Reznik (7)
  5. Jonathan Coleman (7)
  6. Renzo Dinatale (7)

More People

Years
  1. 2023 (2)
  2. 2022 (3)
  3. 2021 (3)
  4. 2020 (1)
  5. 2019 (1)
  6. 2016 (2)
Publications
  1. Journal of Clinical Oncology (3)
  2. Cancer Discovery (2)
  3. Cancer Cell (1)
  4. Cell (1)
  5. Cell Metabolism (1)
  6. European Urology Focus (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. American Society of Clinical Oncology (3)
  3. Cell Press (2)
  4. Biomed Central Ltd (1)
  5. Elsevier B.V. (1)
  6. Elsevier Inc. (1)

More Publishers

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Functional and translational consequences of immunometabolic coevolution in ccRCC
    Meeting Abstract

    Reznik, E.; Tang, C.; Xie, A.; Liu, E. M.; Kuo, F.; Kim, M.; Golkaram, M.; Chen, Y.; Gupta, S.; Motzer, R.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Immunometabolic coevolution defines unique microenvironmental niches in ccRCC
    Journal Article

    Tang, C.; Xie, A. X.; Liu, E. M.; Kuo, F.; Kim, M.; DiNatale, R. G.; Golkaram, M.; Chen, Y. B.; Gupta, S.; Motzer, R. J.; more...
    Cell Metabolism (2023)

    Fulltext@MSK | Save
  • A robust, trial-agnostic gene signature for response to tyrosine kinase inhibition in ccRRCC
    Meeting Abstract

    Khaleel, S. S.; Liu, M.; Kuo, F.; Kotecha, R.; Lee, C. H.; Voss, M. H.; Motzer, R. J.; Hakimi, A. A.; Reznik, E.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A targetable myeloid inflammatory state governs disease recurrence in clear-cell renal cell carcinoma
    Journal Article

    Rappold, P. M.; Vuong, L.; Leibold, J.; Chakiryan, N. H.; Curry, M.; Kuo, F.; Sabio, E.; Jiang, H.; Nixon, B. G.; Liu, M.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • High response rate and durability driven by HLA genetic diversity in patients with kidney cancer treated with lenvatinib and pembrolizumab
    Journal Article

    Lee, C. H.; DiNatale, R. G.; Chowell, D.; Krishna, C.; Makarov, V.; Valero, C.; Vuong, L.; Lee, M.; Weiss, K.; Hoen, D.; more...
    Molecular Cancer Research (2021)

    Fulltext@MSK | Save
  • Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
    Journal Article

    Krishna, C.; DiNatale, R. G.; Kuo, F.; Srivastava, R. M.; Vuong, L.; Chowell, D.; Gupta, S.; Vanderbilt, C.; Purohit, T. A.; Liu, M.; more...
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • Putative drivers of aggressiveness in TCEB1-mutant renal cell carcinoma: An emerging entity with variable clinical course
    Journal Article

    DiNatale, R. G.; Gorelick, A. N.; Makarov, V.; Blum, K. A.; Silagy, A. W.; Freeman, B.; Chowell, D.; Marcon, J.; Mano, R.; Sanchez, A.; more...
    European Urology Focus (2021)

    Fulltext@MSK | Save
  • Genomic biomarkers of response to lenvatinib/pembrolizumab (Len/Pembro) in patients with advanced renal cell carcinoma
    Meeting Abstract

    Lee, C. H.; DiNatale, R. G.; Chowell, D.; Krishna, C.; Makarov, V.; Shapnik, N.; Murray, S. J.; Carlo, M. I.; Voss, M. H.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Transcriptomic profiling of the tumor microenvironment reveals distinct subgroups of clear cell renal cell cancer: Data from a randomized phase III trial
    Journal Article

    Hakimi, A. A.; Voss, M. H.; Kuo, F.; Sanchez, A.; Liu, M.; Nixon, B. G.; Vuong, L.; Ostrovnaya, I.; Chen, Y. B.; Reuter, V.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save